An Orally Bioavailable Broad-Spectrum Antiviral Inhibits SARS-CoV-2 in Human Airway Epithelial Cell Cultures and Multiple Coronaviruses in Mice

Science Translational Medicine - United States
doi 10.1126/scitranslmed.abb5883
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Potential Host Range of Multiple SARS-like Coronaviruses and an Improved ACE2-Fc Variant That Is Potent Against Both SARS-CoV-2 and SARS-CoV-1

2020English

Dark Proteome of Newly Emerged SARS-CoV-2 in Comparison With Human and Bat Coronaviruses

2020English

Authors’ Response: Plenty of Coronaviruses but No SARS-CoV-2

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2020English

Potential Microenvironment of SARS-CoV-2 Infection in Airway Epithelial Cells Revealed by Human Protein Atlas Database Analysis

2020English

Transcriptional Difference Between SARS-COV-2 and Other Human Coronaviruses Revealed by Sub-Genomic RNA Profiling

2020English

Computational Target-Based Drug Repurposing of Elbasvir, an Antiviral Drug Predicted to Bind Multiple SARS-CoV-2 Proteins

2020English

Analysis of Serologic Cross-Reactivity Between Common Human Coronaviruses and SARS-CoV-2 Using Coronavirus Antigen Microarray

2020English

A Broad-Spectrum Antiviral Molecule, QL47, Selectively Inhibits Eukaryotic Translation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

TMPRSS2 and Furin Are Both Essential for Proteolytic Activation and Spread of SARS-CoV-2 in Human Airway Epithelial Cells and Provide Promising Drug Targets

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy